923288-90-8,
Nilotinib hydrochloride monohydrate,
Nilotinib monohydrochloride monohydrate,
Nilotinib HCl monohydrate,
Nilotinib (monohydrochloride monohydrate),
UNII-5JHU0N1R6K,
5JHU0N1R6K,
Nilotinib hydrochloride hydrate [JAN],
4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide;hydrate;hydrochloride,
Nilotinib hydrochloride hydrate (JAN),
Nilotinib hydrochloride hydrate,
Tasigna (TN),
Nilotinib HCl hydrate,
Nilotinib hydrochloride monohydrate [Orange Book],
SCHEMBL235245,
CHEMBL1201740,
KS-00000HOJ,
C28H22F3N7O.HCl.H2O,
DTXSID00238967,
YCBPQSYLYYBPDW-UHFFFAOYSA-N,
AOB87113,
BCP11142,
HY-10159A,
MFCD18251359,
NILOTINIB HYDRATE HYDROCHLORIDE,
CF-0252,
CS-1212,
4-Methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-benzamide hydrochloride hydrate,
AC-28467,
AK468724,
Benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-, hydrochloride, hydrate (1:1:1),
SC-82023,
FT-0700805,
X8407,
D06413,
4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide hydrochloride hydrate,
4-Methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-{[4-(3-pyridinyl)-2-pyrimidinyl]amino}benzamide hydrochloride hydrate,
4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide monohydrochloride monohydrate,
Tasigna,
AMN-107,
AMN107,
923288-90-8 (HCl hydrate),
ACN-037465,
2162S,
A3660,
A15186,